Airway proteomics reveals broad residual anti-inflammatory effects of prednisolone in mepolizumab-treated asthma.
Howell I. et al, (2024), J Allergy Clin Immunol
Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022-23.
Cane J. et al, (2024), J Infect, 88
Nanopore sequencing of influenza A and B in Oxfordshire and the United Kingdom, 2022-23
Cane J. et al, (2023)
Additional effects of oral prednisolone following mepolizumab on the nasal transcriptome
Howell I. et al, (2023), EUROPEAN RESPIRATORY JOURNAL, 62
Identifying Bacterial Airways Infection in Stable Severe Asthma Using Oxford Nanopore Sequencing Technologies.
Jabeen MF. et al, (2022), Microbiol Spectr, 10
Method development for flow-cytometric analysis of primary human airway epithelia infected with non-typeable Haemophilus influenzae
Horton KL. et al, (2022), EUROPEAN RESPIRATORY JOURNAL, 60
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.
Zhuang X. et al, (2021), iScience, 24
Azithromycin versus standard care in patients with mild-to-moderate COVID-19 (ATOMIC2): an open-label, randomised trial.
Hinks TSC. et al, (2021), Lancet Respir Med, 9, 1130 - 1140
Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial.
Ramakrishnan S. et al, (2021), Lancet Respir Med, 9, 763 - 772
The circadian clock component BMAL1 regulates SARS-CoV-2 entry and replication in lung epithelial cells.
Zhuang X. et al, (2021), bioRxiv
A Randomised Clinical Trial of Azithromycin Versus Standard Care in Ambulatory COVID-19 – The ATOMIC2 Trial
Hinks TSC. et al, (2021), SSRN Electronic Journal
Inhaled Budesonide in the Treatment of Early COVID-19 Illness: A Randomised Controlled Trial
Ramakrishnan S. et al, (2021)
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
Ramakrishnan S. et al, (2021)
A RANDOMISED CLINICAL TRIAL OF AZITHROMYCIN VERSUS STANDARD CARE IN AMBULATORY COVID-19-THE ATOMIC2 TRIAL
Hinks TSC. et al, (2021), THORAX, 76, A35 - A35
Antimicrobial Peptides SLPI and Beta Defensin-1 in Sputum are Negatively Correlated with FEV1.
Cane J. et al, (2021), Int J Chron Obstruct Pulmon Dis, 16, 1437 - 1447
Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial
Ramakrishnan S. et al, (2021), EUROPEAN RESPIRATORY JOURNAL, 58
Tight junction molecules are unresponsive in the epithelium of COPD patients during RV infection
Lababidi R. et al, (2021), EUROPEAN RESPIRATORY JOURNAL, 58
Epithelial Cell Regulation of Type 2 Cytokine Release by Peripheral Blood Mononuclear Cells
Southern A. et al, (2020)